DIGIT AL HEALTH
has just been refreshed, with around 165 UK Digital Health companies.
eu.eventscloud.com/ ehome/200208923/first-100-digital/ Digital Health is rightly seen as the answer to
many of the challenges facing global healthcare, and ‘The UK’s Beyond 100 Expanded Playbook’, provides an accessible showcase of some of the top digital health solutions that could be the right fit for your digital transformation in your healthcare organisation.
Genomics in the UK and the Future for Global Health Genomics has played an expanding role in the NHS over the last seven decade. The UK’s core strengths in genomics is underpinned through its life sciences heritage and strong foundations. The time is now to focus on its future where the UK is pushing the boundaries of discovery. The growth in precision medicine and importance
of genomic technologies, along with a focus on preventative medicine and early detection of disease, has promoted extensive innovation globally.
Knowledge of an individual’s make-up
can help understand their pre-disposition toward certain genetic diseases, inform the best course of treatment and inform development of precision medicine.
A rapidly evolving sector The UK has built an end-to-end ecosystem that harnesses the power of genomic medicine and science to improve health care, benefits to patients and broader innovation. Building on our continued investment and leadership in Genomics, it has helped establish the UK’s position as one of the most advanced genomic centric healthcare systems in the world today. From seminal discoveries in fundamental
science to translation into clinical practice, and improved patient outcomes, the UK has made a vast contribution to this rapidly evolving and exciting field. The UK genomics sector is at the forefront of these technologies and its growth is driven by a thriving community of entrepreneurs, scaling SMEs, global companies, and an active investor base. The sector is supported by academic excellence at scale, research institutes, the NHS, government support, and unique data resources, such as the UK Biobank and Genomics England. We are committed to a future where genomics
greatly improves the mental and physical wellbeing of the UK population and millions more worldwide. This translates to developing a better understanding of the genetic causes of disease, along with provision of tailored therapies, meaning patients get the treatments and advice that work for them. Predictive interventions and addressing diseases before they appear, are also starting to deliver on the promise of preventative medicine at scale. Genomics is rapidly changing the future of medicine and has already had great impact and an amazing power to continue improving health outcomes globally. It provides an incredible opportunity to achieve faster, accurate diagnosis, and has driven a revolutionary shift toward precision and personalised medicine, meaning better, more
DUSSELDORF 2022 UKHEALT HCARE P A VILIO N. COM 25
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
